Report Detail
Global Spine Surgery Biologics Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4523979 |
- 17 March, 2023 |
- Global |
- 103 Pages |
- GIR (Global Info Research) |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Spine Surgery Biologics market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Spinal fusion products are used in spinal fusion surgery. The products are involved in removing the damaged disc and replacing it with any fusion products.
This report is a detailed and comprehensive analysis for global Spine Surgery Biologics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Spine Surgery Biologics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Spine Surgery Biologics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Spine Surgery Biologics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Spine Surgery Biologics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Spine Surgery Biologics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Spine Surgery Biologics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, J & J, Stryker Corporation, Nuvasive and Zimmer Biomet, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Spine Surgery Biologics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
Other
Market segment by Application
Open Surgery
Minimally Invasive Surgery
Market segment by players, this report covers
Medtronic
J & J
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Spine Surgery Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Spine Surgery Biologics, with revenue, gross margin and global market share of Spine Surgery Biologics from 2018 to 2023.
Chapter 3, the Spine Surgery Biologics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Spine Surgery Biologics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Spine Surgery Biologics.
Chapter 13, to describe Spine Surgery Biologics research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Spine Surgery Biologics
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Spine Surgery Biologics by Type
- 1.3.1 Overview: Global Spine Surgery Biologics Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Spine Surgery Biologics Consumption Value Market Share by Type in 2022
- 1.3.3 Bone Graft
- 1.3.4 Bone Graft Substitute
- 1.3.5 Platelet Rich Plasma (PRP)
- 1.3.6 Other
- 1.4 Global Spine Surgery Biologics Market by Application
- 1.4.1 Overview: Global Spine Surgery Biologics Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Open Surgery
- 1.4.3 Minimally Invasive Surgery
- 1.5 Global Spine Surgery Biologics Market Size & Forecast
- 1.6 Global Spine Surgery Biologics Market Size and Forecast by Region
- 1.6.1 Global Spine Surgery Biologics Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Spine Surgery Biologics Market Size by Region, (2018-2029)
- 1.6.3 North America Spine Surgery Biologics Market Size and Prospect (2018-2029)
- 1.6.4 Europe Spine Surgery Biologics Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Spine Surgery Biologics Market Size and Prospect (2018-2029)
- 1.6.6 South America Spine Surgery Biologics Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Spine Surgery Biologics Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 Medtronic
- 2.1.1 Medtronic Details
- 2.1.2 Medtronic Major Business
- 2.1.3 Medtronic Spine Surgery Biologics Product and Solutions
- 2.1.4 Medtronic Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Medtronic Recent Developments and Future Plans
- 2.2 J & J
- 2.2.1 J & J Details
- 2.2.2 J & J Major Business
- 2.2.3 J & J Spine Surgery Biologics Product and Solutions
- 2.2.4 J & J Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 J & J Recent Developments and Future Plans
- 2.3 Stryker Corporation
- 2.3.1 Stryker Corporation Details
- 2.3.2 Stryker Corporation Major Business
- 2.3.3 Stryker Corporation Spine Surgery Biologics Product and Solutions
- 2.3.4 Stryker Corporation Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Stryker Corporation Recent Developments and Future Plans
- 2.4 Nuvasive
- 2.4.1 Nuvasive Details
- 2.4.2 Nuvasive Major Business
- 2.4.3 Nuvasive Spine Surgery Biologics Product and Solutions
- 2.4.4 Nuvasive Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Nuvasive Recent Developments and Future Plans
- 2.5 Zimmer Biomet
- 2.5.1 Zimmer Biomet Details
- 2.5.2 Zimmer Biomet Major Business
- 2.5.3 Zimmer Biomet Spine Surgery Biologics Product and Solutions
- 2.5.4 Zimmer Biomet Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Zimmer Biomet Recent Developments and Future Plans
- 2.6 Orthofix International
- 2.6.1 Orthofix International Details
- 2.6.2 Orthofix International Major Business
- 2.6.3 Orthofix International Spine Surgery Biologics Product and Solutions
- 2.6.4 Orthofix International Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Orthofix International Recent Developments and Future Plans
- 2.7 Globus Medical
- 2.7.1 Globus Medical Details
- 2.7.2 Globus Medical Major Business
- 2.7.3 Globus Medical Spine Surgery Biologics Product and Solutions
- 2.7.4 Globus Medical Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Globus Medical Recent Developments and Future Plans
- 2.8 alphatec spine
- 2.8.1 alphatec spine Details
- 2.8.2 alphatec spine Major Business
- 2.8.3 alphatec spine Spine Surgery Biologics Product and Solutions
- 2.8.4 alphatec spine Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 alphatec spine Recent Developments and Future Plans
- 2.9 K2M
- 2.9.1 K2M Details
- 2.9.2 K2M Major Business
- 2.9.3 K2M Spine Surgery Biologics Product and Solutions
- 2.9.4 K2M Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 K2M Recent Developments and Future Plans
- 2.10 Exactech
- 2.10.1 Exactech Details
- 2.10.2 Exactech Major Business
- 2.10.3 Exactech Spine Surgery Biologics Product and Solutions
- 2.10.4 Exactech Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Exactech Recent Developments and Future Plans
- 2.11 Wright Medical Technology
- 2.11.1 Wright Medical Technology Details
- 2.11.2 Wright Medical Technology Major Business
- 2.11.3 Wright Medical Technology Spine Surgery Biologics Product and Solutions
- 2.11.4 Wright Medical Technology Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 Wright Medical Technology Recent Developments and Future Plans
- 2.12 X-Spine
- 2.12.1 X-Spine Details
- 2.12.2 X-Spine Major Business
- 2.12.3 X-Spine Spine Surgery Biologics Product and Solutions
- 2.12.4 X-Spine Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 X-Spine Recent Developments and Future Plans
- 2.13 Nutech
- 2.13.1 Nutech Details
- 2.13.2 Nutech Major Business
- 2.13.3 Nutech Spine Surgery Biologics Product and Solutions
- 2.13.4 Nutech Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
- 2.13.5 Nutech Recent Developments and Future Plans
- 2.14 Arthrex
- 2.14.1 Arthrex Details
- 2.14.2 Arthrex Major Business
- 2.14.3 Arthrex Spine Surgery Biologics Product and Solutions
- 2.14.4 Arthrex Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
- 2.14.5 Arthrex Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Spine Surgery Biologics Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Spine Surgery Biologics by Company Revenue
- 3.2.2 Top 3 Spine Surgery Biologics Players Market Share in 2022
- 3.2.3 Top 6 Spine Surgery Biologics Players Market Share in 2022
- 3.3 Spine Surgery Biologics Market: Overall Company Footprint Analysis
- 3.3.1 Spine Surgery Biologics Market: Region Footprint
- 3.3.2 Spine Surgery Biologics Market: Company Product Type Footprint
- 3.3.3 Spine Surgery Biologics Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Spine Surgery Biologics Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Spine Surgery Biologics Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Spine Surgery Biologics Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Spine Surgery Biologics Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Spine Surgery Biologics Consumption Value by Type (2018-2029)
- 6.2 North America Spine Surgery Biologics Consumption Value by Application (2018-2029)
- 6.3 North America Spine Surgery Biologics Market Size by Country
- 6.3.1 North America Spine Surgery Biologics Consumption Value by Country (2018-2029)
- 6.3.2 United States Spine Surgery Biologics Market Size and Forecast (2018-2029)
- 6.3.3 Canada Spine Surgery Biologics Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Spine Surgery Biologics Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Spine Surgery Biologics Consumption Value by Type (2018-2029)
- 7.2 Europe Spine Surgery Biologics Consumption Value by Application (2018-2029)
- 7.3 Europe Spine Surgery Biologics Market Size by Country
- 7.3.1 Europe Spine Surgery Biologics Consumption Value by Country (2018-2029)
- 7.3.2 Germany Spine Surgery Biologics Market Size and Forecast (2018-2029)
- 7.3.3 France Spine Surgery Biologics Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Spine Surgery Biologics Market Size and Forecast (2018-2029)
- 7.3.5 Russia Spine Surgery Biologics Market Size and Forecast (2018-2029)
- 7.3.6 Italy Spine Surgery Biologics Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Spine Surgery Biologics Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Spine Surgery Biologics Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Spine Surgery Biologics Market Size by Region
- 8.3.1 Asia-Pacific Spine Surgery Biologics Consumption Value by Region (2018-2029)
- 8.3.2 China Spine Surgery Biologics Market Size and Forecast (2018-2029)
- 8.3.3 Japan Spine Surgery Biologics Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Spine Surgery Biologics Market Size and Forecast (2018-2029)
- 8.3.5 India Spine Surgery Biologics Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Spine Surgery Biologics Market Size and Forecast (2018-2029)
- 8.3.7 Australia Spine Surgery Biologics Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Spine Surgery Biologics Consumption Value by Type (2018-2029)
- 9.2 South America Spine Surgery Biologics Consumption Value by Application (2018-2029)
- 9.3 South America Spine Surgery Biologics Market Size by Country
- 9.3.1 South America Spine Surgery Biologics Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Spine Surgery Biologics Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Spine Surgery Biologics Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Spine Surgery Biologics Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Spine Surgery Biologics Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Spine Surgery Biologics Market Size by Country
- 10.3.1 Middle East & Africa Spine Surgery Biologics Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Spine Surgery Biologics Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Spine Surgery Biologics Market Size and Forecast (2018-2029)
- 10.3.4 UAE Spine Surgery Biologics Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Spine Surgery Biologics Market Drivers
- 11.2 Spine Surgery Biologics Market Restraints
- 11.3 Spine Surgery Biologics Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Spine Surgery Biologics Industry Chain
- 12.2 Spine Surgery Biologics Upstream Analysis
- 12.3 Spine Surgery Biologics Midstream Analysis
- 12.4 Spine Surgery Biologics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Spine Surgery Biologics. Industry analysis & Market Report on Spine Surgery Biologics is a syndicated market report, published as Global Spine Surgery Biologics Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Spine Surgery Biologics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
